Innorna
1 known investors
Innorna develops an mRNA medicines platform with proprietary lipid nanoparticle delivery technology and in-house manufacturing capabilities for therapeutic applications in metabolic disease and autoimmune conditions. The company partners with pharmaceutical and biotechnology firms to advance clinical programs and commercialize RNA-based therapies.